WST: West Pharmaceutical Services Inc Financial Statements
Balance sheet, income statement, and cash flow statements for West Pharmaceutical Services Inc (WST).
$23.72B Market Cap.
WST Market Cap. (MRY)
WST Shares Outstanding (MRY)
WST Assets (MRY)
Total Assets
$3.64B
Total Liabilities
$961.10M
Total Investments
$202.10M
WST Income (MRY)
Revenue
$2.89B
Net Income
$492.70M
Operating Expense
$428.60M
WST Cash Flow (MRY)
CF Operations
$653.40M
CF Investing
-$378.70M
CF Financing
-$622.60M
WST Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $3,643,400,000 (-4.86%) | $3,829,500,000 (5.88%) | $3,616,800,000 (9.14%) | $3,313,800,000 (18.61%) |
Assets Current | $1,538,100,000 (-20.57%) | $1,936,400,000 (0.88%) | $1,919,500,000 (10.19%) | $1,742,000,000 (26.81%) |
Assets Non-Current | $2,105,300,000 (11.21%) | $1,893,100,000 (11.54%) | $1,697,300,000 (7.98%) | $1,571,800,000 (10.68%) |
Goodwill & Intangible Assets | $116,800,000 (-5.50%) | $123,600,000 (-1.67%) | $125,700,000 (-5.42%) | $132,900,000 (-6.14%) |
Shareholders Equity | $2,682,300,000 (-6.90%) | $2,881,000,000 (7.30%) | $2,684,900,000 (14.97%) | $2,335,400,000 (25.93%) |
Property Plant & Equipment Net | $1,686,100,000 (11.48%) | $1,512,500,000 (19.78%) | $1,262,700,000 (12.06%) | $1,126,800,000 (11.40%) |
Cash & Equivalents | $484,600,000 (-43.25%) | $853,900,000 (-4.52%) | $894,300,000 (17.27%) | $762,600,000 (23.90%) |
Accumulated Other Comprehensive Income | -$258,100,000 (-79.49%) | -$143,800,000 (21.42%) | -$183,000,000 (-14.66%) | -$159,600,000 (-44.30%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $202,100,000 (-3.76%) | $210,000,000 (2.49%) | $204,900,000 (-1.35%) | $207,700,000 (-3.26%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $202,100,000 (-3.76%) | $210,000,000 (2.49%) | $204,900,000 (-1.35%) | $207,700,000 (-3.26%) |
Inventory | $377,000,000 (-13.27%) | $434,700,000 (4.80%) | $414,800,000 (9.62%) | $378,400,000 (17.77%) |
Trade & Non-Trade Receivables | $552,500,000 (7.91%) | $512,000,000 (0.91%) | $507,400,000 (3.76%) | $489,000,000 (26.91%) |
Trade & Non-Trade Payables | $239,300,000 (-1.28%) | $242,400,000 (12.53%) | $215,400,000 (-7.24%) | $232,200,000 (8.96%) |
Accumulated Retained Earnings (Deficit) | $3,956,600,000 (12.29%) | $3,523,400,000 (17.93%) | $2,987,800,000 (21.62%) | $2,456,700,000 (33.03%) |
Tax Assets | $26,000,000 (1.17%) | $25,700,000 (-60.82%) | $65,600,000 (35.26%) | $48,500,000 (203.13%) |
Tax Liabilities | $52,000,000 (77.47%) | $29,300,000 (-25.06%) | $39,100,000 (25.32%) | $31,200,000 (-14.29%) |
Total Debt | $302,300,000 (-2.17%) | $309,000,000 (-2.80%) | $317,900,000 (-2.27%) | $325,300,000 (-0.12%) |
Debt Current | $17,900,000 (-88.20%) | $151,700,000 (733.52%) | $18,200,000 (-65.98%) | $53,500,000 (331.45%) |
Debt Non-Current | $284,400,000 (80.80%) | $157,300,000 (-47.51%) | $299,700,000 (10.26%) | $271,800,000 (-13.25%) |
Total Liabilities | $961,100,000 (1.33%) | $948,500,000 (1.78%) | $931,900,000 (-4.75%) | $978,400,000 (4.16%) |
Liabilities Current | $550,400,000 (-18.07%) | $671,800,000 (29.44%) | $519,000,000 (-12.64%) | $594,100,000 (18.02%) |
Liabilities Non-Current | $410,700,000 (48.43%) | $276,700,000 (-32.99%) | $412,900,000 (7.44%) | $384,300,000 (-11.84%) |
WST Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $2,893,200,000 (-1.92%) | $2,949,800,000 (2.18%) | $2,886,900,000 (1.95%) | $2,831,600,000 (31.89%) |
Cost of Revenue | $1,894,700,000 (4.07%) | $1,820,600,000 (3.99%) | $1,750,700,000 (5.73%) | $1,655,800,000 (20.06%) |
Selling General & Administrative Expense | $338,500,000 (-4.22%) | $353,400,000 (11.52%) | $316,900,000 (-12.65%) | $362,800,000 (20.13%) |
Research & Development Expense | $69,100,000 (1.02%) | $68,400,000 (16.92%) | $58,500,000 (10.80%) | $52,800,000 (12.58%) |
Operating Expenses | $428,600,000 (-5.43%) | $453,200,000 (12.68%) | $402,200,000 (-5.03%) | $423,500,000 (17.35%) |
Interest Expense | $3,000,000 (-66.67%) | $9,000,000 (13.92%) | $7,900,000 (-3.66%) | $8,200,000 (0.00%) |
Income Tax Expense | $107,500,000 (-12.10%) | $122,300,000 (6.63%) | $114,700,000 (7.00%) | $107,200,000 (47.86%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | $492,700,000 (-16.97%) | $593,400,000 (1.28%) | $585,900,000 (-11.47%) | $661,800,000 (91.16%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | $492,700,000 (-16.97%) | $593,400,000 (1.28%) | $585,900,000 (-11.47%) | $661,800,000 (91.16%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | $492,700,000 (-16.97%) | $593,400,000 (1.28%) | $585,900,000 (-11.47%) | $661,800,000 (91.16%) |
Weighted Average Shares | $73,000,000 (-1.75%) | $74,300,000 (-0.13%) | $74,400,000 (0.00%) | $74,400,000 (0.68%) |
Weighted Average Shares Diluted | $73,700,000 (-2.12%) | $75,300,000 (-0.66%) | $75,800,000 (-0.66%) | $76,300,000 (0.66%) |
Earning Before Interest & Taxes (EBIT) | $603,200,000 (-16.77%) | $724,700,000 (2.29%) | $708,500,000 (-8.84%) | $777,200,000 (82.06%) |
Gross Profit | $998,500,000 (-11.57%) | $1,129,200,000 (-0.62%) | $1,136,200,000 (-3.37%) | $1,175,800,000 (53.14%) |
Operating Income | $569,900,000 (-15.70%) | $676,000,000 (-7.90%) | $734,000,000 (-2.43%) | $752,300,000 (84.89%) |
WST Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$378,700,000 (-2.71%) | -$368,700,000 (-27.93%) | -$288,200,000 (-13.87%) | -$253,100,000 (-41.00%) |
Net Cash Flow from Financing | -$622,600,000 (-35.47%) | -$459,600,000 (-56.54%) | -$293,600,000 (-74.66%) | -$168,100,000 (-22.61%) |
Net Cash Flow from Operations | $653,400,000 (-15.85%) | $776,500,000 (7.25%) | $724,000,000 (23.97%) | $584,000,000 (23.60%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$369,300,000 (-814.11%) | -$40,400,000 (-130.68%) | $131,700,000 (-10.47%) | $147,100,000 (-16.61%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | -$2,200,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$377,000,000 (-4.14%) | -$362,000,000 (-27.20%) | -$284,600,000 (-12.31%) | -$253,400,000 (-45.30%) |
Issuance (Repayment) of Debt Securities | -$27,600,000 (-1050.00%) | -$2,400,000 (94.73%) | -$45,500,000 (-1968.18%) | -$2,200,000 (4.35%) |
Issuance (Purchase) of Equity Shares | -$541,100,000 (-32.85%) | -$407,300,000 (-102.33%) | -$201,300,000 (-64.33%) | -$122,500,000 (-31.58%) |
Payment of Dividends & Other Cash Distributions | -$59,100,000 (-3.68%) | -$57,000,000 (-5.36%) | -$54,100,000 (-5.87%) | -$51,100,000 (-6.24%) |
Effect of Exchange Rate Changes on Cash | -$21,400,000 (-287.72%) | $11,400,000 (208.57%) | -$10,500,000 (33.12%) | -$15,700,000 (-176.59%) |
Share Based Compensation | $18,700,000 (-19.74%) | $23,300,000 (-1.69%) | $23,700,000 (-36.80%) | $37,500,000 (10.29%) |
Depreciation Amortization & Accretion | $155,400,000 (13.18%) | $137,300,000 (13.85%) | $120,600,000 (-1.39%) | $122,300,000 (12.10%) |
WST Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 34.50% (-9.92%) | 38.30% (-2.79%) | 39.40% (-5.06%) | 41.50% (15.92%) |
Profit Margin | 17.00% (-15.42%) | 20.10% (-0.99%) | 20.30% (-13.25%) | 23.40% (45.34%) |
EBITDA Margin | 26.20% (-10.27%) | 29.20% (1.74%) | 28.70% (-9.75%) | 31.80% (27.20%) |
Return on Average Equity (ROAE) | 18.40% (-12.80%) | 21.10% (-10.97%) | 23.70% (-24.76%) | 31.50% (51.44%) |
Return on Average Assets (ROAA) | 13.70% (-13.29%) | 15.80% (-8.14%) | 17.20% (-21.10%) | 21.80% (57.97%) |
Return on Sales (ROS) | 20.80% (-15.45%) | 24.60% (0.41%) | 24.50% (-10.58%) | 27.40% (37.69%) |
Return on Invested Capital (ROIC) | 22.40% (-22.49%) | 28.90% (-5.86%) | 30.70% (-18.57%) | 37.70% (58.40%) |
Dividend Yield | 0.20% (0.00%) | 0.20% (-33.33%) | 0.30% (200.00%) | 0.10% (-50.00%) |
Price to Earnings Ratio (P/E) | 48.53 (9.98%) | 44.13 (47.55%) | 29.91 (-43.32%) | 52.76 (-12.85%) |
Price to Sales Ratio (P/S) | 8.27 (-6.81%) | 8.87 (46.23%) | 6.07 (-50.78%) | 12.32 (26.36%) |
Price to Book Ratio (P/B) | 8.84 (-2.20%) | 9.04 (39.34%) | 6.49 (-56.38%) | 14.88 (31.72%) |
Debt to Equity Ratio (D/E) | 0.36 (8.81%) | 0.33 (-5.19%) | 0.35 (-17.18%) | 0.42 (-17.19%) |
Earnings Per Share (EPS) | 6.75 (-15.41%) | 7.98 (1.40%) | 7.87 (-11.47%) | 8.89 (89.96%) |
Sales Per Share (SPS) | 39.63 (-0.17%) | 39.7 (2.32%) | 38.8 (1.95%) | 38.06 (31.01%) |
Free Cash Flow Per Share (FCFPS) | 3.79 (-32.14%) | 5.58 (-5.54%) | 5.91 (32.90%) | 4.44 (10.16%) |
Book Value Per Share (BVPS) | 36.74 (-5.24%) | 38.77 (7.45%) | 36.09 (14.96%) | 31.39 (25.08%) |
Tangible Assets Book Value Per Share (TABVPS) | 48.31 (-3.14%) | 49.88 (6.30%) | 46.92 (9.75%) | 42.75 (19.13%) |
Enterprise Value Over EBIT (EV/EBIT) | 39 (11.43%) | 35 (45.83%) | 24 (-45.45%) | 44 (-10.20%) |
Enterprise Value Over EBITDA (EV/EBITDA) | 31.03 (5.04%) | 29.54 (44.10%) | 20.5 (-46.36%) | 38.21 (-1.29%) |
Asset Turnover | 0.8 (1.90%) | 0.79 (-7.29%) | 0.85 (-8.99%) | 0.93 (8.98%) |
Current Ratio | 2.79 (-3.02%) | 2.88 (-22.07%) | 3.7 (26.13%) | 2.93 (7.44%) |
Dividends | $0.81 (5.19%) | $0.77 (5.48%) | $0.73 (5.80%) | $0.69 (6.15%) |
Free Cash Flow (FCF) | $276,400,000 (-33.32%) | $414,500,000 (-5.67%) | $439,400,000 (32.91%) | $330,600,000 (10.90%) |
Enterprise Value (EV) | $23,536,564,638 (-7.56%) | $25,461,442,600 (49.82%) | $16,994,563,490 (-50.56%) | $34,371,727,132 (65.64%) |
Earnings Before Tax (EBT) | $600,200,000 (-16.14%) | $715,700,000 (2.16%) | $700,600,000 (-8.89%) | $769,000,000 (83.66%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | $758,600,000 (-12.00%) | $862,000,000 (3.97%) | $829,100,000 (-7.83%) | $899,500,000 (67.82%) |
Invested Capital | $2,793,900,000 (12.24%) | $2,489,200,000 (3.90%) | $2,395,700,000 (11.45%) | $2,149,500,000 (15.63%) |
Working Capital | $987,700,000 (-21.90%) | $1,264,600,000 (-9.70%) | $1,400,500,000 (22.01%) | $1,147,900,000 (31.90%) |
Tangible Asset Value | $3,526,600,000 (-4.84%) | $3,705,900,000 (6.15%) | $3,491,100,000 (9.75%) | $3,180,900,000 (19.93%) |
Market Capitalization | $23,722,664,638 (-8.95%) | $26,053,242,600 (49.53%) | $17,423,663,490 (-49.85%) | $34,744,127,132 (65.89%) |
Average Equity | $2,672,950,000 (-5.15%) | $2,818,025,000 (13.79%) | $2,476,575,000 (17.94%) | $2,099,825,000 (25.93%) |
Average Assets | $3,602,550,000 (-3.79%) | $3,744,350,000 (10.21%) | $3,397,500,000 (12.04%) | $3,032,400,000 (21.11%) |
Invested Capital Average | $2,695,625,000 (7.44%) | $2,508,875,000 (8.71%) | $2,307,850,000 (11.91%) | $2,062,200,000 (14.91%) |
Shares | 72,422,349 (-2.12%) | 73,989,670 (-0.06%) | 74,032,987 (-0.06%) | 74,079,715 (0.21%) |
